| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.200 | None | 1.000 | 27 | 1 | 1991 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.200 | None | 1.000 | 21 | 1 | 1993 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.200 | None | 1.000 | 16 | 1 | 1994 | 2017 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.200 | None | 1.000 | 15 | 0 | 1996 | 2019 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.200 | None | 1.000 | 12 | 0 | 1996 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 11 | 0 | 2000 | 2016 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.150 | None | 1.000 | 5 | 0 | 1995 | 2016 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.130 | None | 1.000 | 3 | 0 | 2007 | 2016 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 1994 | 2016 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2014 | 2016 | ||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2012 | 2018 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
ring finger protein 43 | 0.584 | 0.577 | 0.73 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
epithelial cell adhesion molecule | 0.451 | 0.885 | 1.3E-07 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 2001 | 2017 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2003 | 2019 | ||||||||
|
mucin 4, cell surface associated | 0.506 | 0.769 | 2.8E-54 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2001 | 2013 | ||||||||
|
mesothelin | 0.525 | 0.692 | 5.9E-25 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2001 | 2020 | ||||||||
|
high mobility group AT-hook 1 | 0.494 | 0.769 | 0.83 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2006 | 2013 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2007 | 2018 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2001 | 2014 | |||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2013 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2000 | 2008 |